Skip to main content
. 2016 Apr 24;31(4):365–377. doi: 10.1093/arclin/acw017

Table 1.

Pearson correlation coefficients between MASQ Total Score, Attention and Verbal Memory subscales and a selected list of neurocognitive measures (n = 165)

MASQ
Mean Stdev Total AC VM
MASQ Total Score and Subscales (Verbal Memory and Attention)
 MASQ Total 93.24 23.90
 MASQ Attention (AC) 15.64 4.61 0.892**
 MASQ Verbal Memory (VM) 17.16 5.28 0.901** 0.770**
Post-treatment changes in neurocognitive tests
 CVLT-2-LDFR 0.28 0.92 −0.090 −0.089 −0.051
 CVLT-2-Trial 1 −0.05 1.25 −0.006 −0.043 −0.034
 CVLT-2-MRR 0.09 1.08 −0.082 −0.008 −0.016
 CVLT-2-List B −0.18 0.98 −0.052 −0.025 −0.053
 PASAT 2″ 0.34 0.71 −0.124 −0.087 −0.109
 D-KEFS TMT-Visual Scanning 0.07 0.62 −0.049 0.006 −0.134
 D-KEFS TMT-Number Sequencing 0.22 1.01 −0.200* −0.195* −0.131
 D-KEFS TMT-Letter Sequencing 0.31 0.93 −0.278** −0.244** −0.286**
 D-KEFS CWI-Color Naming 0.002 0.74 −0.003 −0.002 0.035
 D-KEFS CWI-Word Reading −0.13 0.60 −0.030 −0.042 −0.064
 D-KEFS CWI-Inhibition 0.18 0.65 −0.055 −0.058 −0.080
 CPT-Distractibility 0.05 0.87 0.006 0.020 0.041
 CPT-Vigilance 0.16 0.65 −0.017 0.009 0.005

Notes: Listed are the Pearson correlation coefficients between the MASQ scores measured at 6 months post-treatment and the changes of neurocognitive performance between baseline and 6 months post treatment. The MASQ was scored so that a higher score represented worse outcomes (greater problems or issues). Thus, a negative correlation was the anticipated direction of correlation, meaning that a decline in neurocognitive performance at 6-months post-treatment was associated with more self-reported MASQ problems.

*p < .05; **p < .01.